Erchonia Corporation

Erchonia Corporation, founded in 1996 by the Shanks family, specializes in low level laser therapy (LLLT) devices, also known as 3LT® technology. Headquartered in Melbourne, Florida, the company is recognized as a leader in this field, having developed the first FDA-cleared non-thermal low level laser in 2002. Erchonia is dedicated to providing non-invasive, drug-free therapeutic solutions for pain management and other physical ailments through scientifically validated laser technology. The company operates as a self-reliant manufacturer, overseeing all aspects of product creation, from research and development to fabrication. With over 18 FDA market clearances, Erchonia offers a range of portable and ergonomic laser therapy products designed for both human and veterinary applications. Their commitment to rigorous clinical research ensures the safety and efficacy of their devices. Erchonia serves healthcare providers, including chiropractors and veterinarians, as well as patients seeking alternative pain relief options.

• Employees 59
• Founded 1996
• Annual Revenue $39165000